Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.

Internal medicine journal - 1 Jan 2017

Murphy Caitlin, Turner Natalie, Wong Hui-Li, Sinnathamby Mathu, Tie Jeanne, Lee Belinda, Desai Jayesh, Skinner Iain, Christie Michael, Hutchinson Ryan, Lunke Sebastian, Waring Paul, Gibbs Peter, Tran Ben

Abstract excerpt

BACKGROUND/AIM: Data suggest aspirin improves survival in colorectal cancer (CRC) harbouring PIK3CA mutations. The impact of aspirin is thought predominantly to be through an anti-inflammatory effect. The aim of this study is to explore the effect of aspirin use on survival in a real-world cohort of stage 2 colon cancer (CC) patients. METHODS: A prospective CRC database identified patients diagnosed with stage 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Aspirin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Australia

Share to Class I Phosphatidylinositol 3-Kinases

Share to Colonic Neoplasms

Share to Databases, Factual

Share to Multivariate Analysis

Share to Phosphatidylinositol 3-Kinases

Source

Identifiers

PMID: 27800646
DOI: 10.1111/imj.13312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.PMID 27800646Read ↗

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort StudySemantic proximity Read ↗

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.Semantic proximity Read ↗

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.Semantic proximity Read ↗

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.Semantic proximity Read ↗

Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis.Semantic proximity Read ↗

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).Semantic proximity Read ↗

Adjuvant aspirin and Cyclooxygenase-2 inhibitors in resected, PIK3CA-mutated colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.Semantic proximity Read ↗

Potential biomarker for aspirin use in colorectal cancer therapy.Semantic proximity Read ↗

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.Semantic proximity Read ↗

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.Semantic proximity Read ↗

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.Semantic proximity Read ↗

The Protective Effects of Aspirin Use from Adverse In Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient SampleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.